▶ 調査レポート

エボラウイルスワクチンの世界市場レポート2020

• 英文タイトル:Global Ebola Virus Vaccine Sales Market Report 2020

Global Ebola Virus Vaccine Sales Market Report 2020「エボラウイルスワクチンの世界市場レポート2020」(市場規模、市場予測)調査レポートです。• レポートコード:20QY06-01048
• 出版社/出版日:QYResearch / 2020年6月1日
• レポート形態:英文、PDF、137ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥456,000 (USD4,000)▷ お問い合わせ
  Multi User¥684,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥912,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、エボラウイルスワクチンのグローバル市場について種類別(生ワクチン、不活化ワクチン)、用途別(病院、医療センター)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・エボラウイルスワクチン市場の概要
・世界の主要地域別エボラウイルスワクチン市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のエボラウイルスワクチン市場規模2015-2026:種類別(生ワクチン、不活化ワクチン)
・世界のエボラウイルスワクチン市場規模2015-2026:用途別(病院、医療センター)
・エボラウイルスワクチンの北米市場規模2015-2020
・エボラウイルスワクチンのヨーロッパ市場規模2015-2020
・エボラウイルスワクチンの中国市場規模2015-2020
・エボラウイルスワクチンの日本市場規模2015-2020
・エボラウイルスワクチンの東南アジア市場規模2015-2020
・エボラウイルスワクチンのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Bavarian Nordic、Crucell、Fab Entech、Inovio Pharmaceuticals、Microbiotix、Mitsubishi Tanabe Pharma、Profectus Biosciences、SIGA Technologies、Tekmira Pharmaceuticals、Vaxart)
・エボラウイルスワクチンの製造コスト分析
・販売チャネル、流通業者、顧客
・エボラウイルスワクチンの市場動向・機会・課題
・調査の結論

Market Analysis and Insights: Global Ebola Virus Vaccine Market
The global Ebola Virus Vaccine market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Ebola Virus Vaccine Scope and Market Size
The global Ebola Virus Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ebola Virus Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Ebola Virus Vaccine market is segmented into
live Vaccine
Inactivated Vaccine

Segment by Application, the Ebola Virus Vaccine market is segmented into
Hospital
Medical Center
The Ebola Virus Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Ebola Virus Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ebola Virus Vaccine Market Share Analysis
Ebola Virus Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ebola Virus Vaccine business, the date to enter into the Ebola Virus Vaccine market, Ebola Virus Vaccine product introduction, recent developments, etc.
The major vendors covered:
Bavarian Nordic
Crucell
Fab Entech
Inovio Pharmaceuticals
Microbiotix
Mitsubishi Tanabe Pharma
Profectus Biosciences
SIGA Technologies
Tekmira Pharmaceuticals
Vaxart

レポート目次

Table of Contents

1 Ebola Virus Vaccine Market Overview
1.1 Ebola Virus Vaccine Product Scope
1.2 Ebola Virus Vaccine Segment by Type
1.2.1 Global Ebola Virus Vaccine Sales by Type (2020-2026)
1.2.2 live Vaccine
1.2.3 Inactivated Vaccine
1.3 Ebola Virus Vaccine Segment by Application
1.3.1 Global Ebola Virus Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Medical Center
1.4 Ebola Virus Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Ebola Virus Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Ebola Virus Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Ebola Virus Vaccine Price Trends (2015-2026)

2 Ebola Virus Vaccine Estimate and Forecast by Region
2.1 Global Ebola Virus Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Ebola Virus Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Ebola Virus Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Ebola Virus Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Ebola Virus Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Ebola Virus Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Ebola Virus Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Ebola Virus Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Ebola Virus Vaccine Estimates and Projections (2015-2026)
2.4.3 China Ebola Virus Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Ebola Virus Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Ebola Virus Vaccine Estimates and Projections (2015-2026)
2.4.6 India Ebola Virus Vaccine Estimates and Projections (2015-2026)
3 Global Ebola Virus Vaccine Competition Landscape by Players
3.1 Global Top Ebola Virus Vaccine Players by Sales (2015-2020)
3.2 Global Top Ebola Virus Vaccine Players by Revenue (2015-2020)
3.3 Global Ebola Virus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ebola Virus Vaccine as of 2019)
3.4 Global Ebola Virus Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Ebola Virus Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Ebola Virus Vaccine Players (Opinion Leaders)
4 Global Ebola Virus Vaccine Market Size by Type
4.1 Global Ebola Virus Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Ebola Virus Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Ebola Virus Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Ebola Virus Vaccine Price by Type (2014-2020)
4.2 Global Ebola Virus Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Ebola Virus Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Ebola Virus Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Ebola Virus Vaccine Price Forecast by Type (2021-2026)
5 Global Ebola Virus Vaccine Market Size by Application
5.1 Global Ebola Virus Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Ebola Virus Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Ebola Virus Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Ebola Virus Vaccine Price by Application (2015-2020)
5.2 Global Ebola Virus Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Ebola Virus Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Ebola Virus Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Ebola Virus Vaccine Price Forecast by Application (2021-2026)

3 North America Ebola Virus Vaccine Market Facts & Figures
3.2 North America Ebola Virus Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Ebola Virus Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Ebola Virus Vaccine Sales Market Share by Application (2015-2020)

4 Europe Ebola Virus Vaccine Market Facts & Figures
4.2 Europe Ebola Virus Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Ebola Virus Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Ebola Virus Vaccine Sales Market Share by Application (2015-2020)

5 China Ebola Virus Vaccine Market Facts & Figures
5.2 China Ebola Virus Vaccine Sales Market Share by Company (2015-2020)
5.3 China Ebola Virus Vaccine Sales Market Share by Type (2015-2020)
5.4 China Ebola Virus Vaccine Sales Market Share by Application (2015-2020)

6 Japan Ebola Virus Vaccine Market Facts & Figures
6.2 Japan Ebola Virus Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Ebola Virus Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Ebola Virus Vaccine Sales Market Share by Application (2015-2020)

7 Southeast Asia Ebola Virus Vaccine Market Facts & Figures
7.2 Southeast Asia Ebola Virus Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Ebola Virus Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Ebola Virus Vaccine Sales Market Share by Application (2015-2020)

8 India Ebola Virus Vaccine Market Facts & Figures
8.2 India Ebola Virus Vaccine Sales Market Share by Company (2015-2020)
8.3 India Ebola Virus Vaccine Sales Market Share by Type (2015-2020)
8.4 India Ebola Virus Vaccine Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Ebola Virus Vaccine Business
12.1 Bavarian Nordic
12.1.1 Bavarian Nordic Ebola Virus Vaccine Corporation Information
12.1.2 Bavarian Nordic Ebola Virus Vaccine Business Overview and Total Revenue
12.1.3 Bavarian Nordic Ebola Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bavarian Nordic Ebola Virus Vaccine Products Offered
12.1.5 Bavarian Nordic Recent Development
12.2 Crucell
12.2.1 Crucell Ebola Virus Vaccine Corporation Information
12.2.2 Crucell Ebola Virus Vaccine Business Overview and Total Revenue
12.2.3 Crucell Ebola Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Crucell Ebola Virus Vaccine Products Offered
12.2.5 Crucell Recent Development
12.3 Fab Entech
12.3.1 Fab Entech Ebola Virus Vaccine Corporation Information
12.3.2 Fab Entech Ebola Virus Vaccine Business Overview and Total Revenue
12.3.3 Fab Entech Ebola Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Fab Entech Ebola Virus Vaccine Products Offered
12.3.5 Fab Entech Recent Development
12.4 Inovio Pharmaceuticals
12.4.1 Inovio Pharmaceuticals Ebola Virus Vaccine Corporation Information
12.4.2 Inovio Pharmaceuticals Ebola Virus Vaccine Business Overview and Total Revenue
12.4.3 Inovio Pharmaceuticals Ebola Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Inovio Pharmaceuticals Ebola Virus Vaccine Products Offered
12.4.5 Inovio Pharmaceuticals Recent Development
12.5 Microbiotix
12.5.1 Microbiotix Ebola Virus Vaccine Corporation Information
12.5.2 Microbiotix Ebola Virus Vaccine Business Overview and Total Revenue
12.5.3 Microbiotix Ebola Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Microbiotix Ebola Virus Vaccine Products Offered
12.5.5 Microbiotix Recent Development
12.6 Mitsubishi Tanabe Pharma
12.6.1 Mitsubishi Tanabe Pharma Ebola Virus Vaccine Corporation Information
12.6.2 Mitsubishi Tanabe Pharma Ebola Virus Vaccine Business Overview and Total Revenue
12.6.3 Mitsubishi Tanabe Pharma Ebola Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Mitsubishi Tanabe Pharma Ebola Virus Vaccine Products Offered
12.6.5 Mitsubishi Tanabe Pharma Recent Development
12.7 Profectus Biosciences
12.7.1 Profectus Biosciences Ebola Virus Vaccine Corporation Information
12.7.2 Profectus Biosciences Ebola Virus Vaccine Business Overview and Total Revenue
12.7.3 Profectus Biosciences Ebola Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Profectus Biosciences Ebola Virus Vaccine Products Offered
12.7.5 Profectus Biosciences Recent Development
12.8 SIGA Technologies
12.8.1 SIGA Technologies Ebola Virus Vaccine Corporation Information
12.8.2 SIGA Technologies Ebola Virus Vaccine Business Overview and Total Revenue
12.8.3 SIGA Technologies Ebola Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 SIGA Technologies Ebola Virus Vaccine Products Offered
12.8.5 SIGA Technologies Recent Development
12.9 Tekmira Pharmaceuticals
12.9.1 Tekmira Pharmaceuticals Ebola Virus Vaccine Corporation Information
12.9.2 Tekmira Pharmaceuticals Ebola Virus Vaccine Business Overview and Total Revenue
12.9.3 Tekmira Pharmaceuticals Ebola Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Tekmira Pharmaceuticals Ebola Virus Vaccine Products Offered
12.9.5 Tekmira Pharmaceuticals Recent Development
12.10 Vaxart
12.10.1 Vaxart Ebola Virus Vaccine Corporation Information
12.10.2 Vaxart Ebola Virus Vaccine Business Overview and Total Revenue
12.10.3 Vaxart Ebola Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Vaxart Ebola Virus Vaccine Products Offered
12.10.5 Vaxart Recent Development

13 Ebola Virus Vaccine Manufacturing Cost Analysis
13.1 Ebola Virus Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Ebola Virus Vaccine
13.4 Ebola Virus Vaccine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Ebola Virus Vaccine Distributors List
14.3 Ebola Virus Vaccine Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

Table 1. Global Ebola Virus Vaccine Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Ebola Virus Vaccine Sales (K MT) Comparison by Application (2020-2026)
Table 3. Global Market Ebola Virus Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Ebola Virus Vaccine Sales (K MT) by Region (2015-2020)
Table 5. Global Ebola Virus Vaccine Sales Market Share by Region (2015-2020)
Table 6. Global Ebola Virus Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Ebola Virus Vaccine Revenue Share by Region (2015-2020)
Table 8. Global Ebola Virus Vaccine Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Ebola Virus Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Ebola Virus Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Ebola Virus Vaccine Revenue Share Forecast by Region (2021-2026)
Table 12. Global Ebola Virus Vaccine (K MT) of Key Companies (2015-2020)
Table 13. Global Ebola Virus Vaccine Sales Share by Company (2015-2020)
Table 14. Global Ebola Virus Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Ebola Virus Vaccine Revenue Share by Company (2015-2020)
Table 16. Global Ebola Virus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ebola Virus Vaccine as of 2019)
Table 17. Global Ebola Virus Vaccine Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Ebola Virus Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Ebola Virus Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Ebola Virus Vaccine Players
Table 22. Global Ebola Virus Vaccine Sales (K MT) by Type (2015-2020)
Table 23. Global Ebola Virus Vaccine Sales Share by Type (2015-2020)
Table 24. Global Ebola Virus Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Ebola Virus Vaccine Price (K MT) by Type (2015-2020)
Table 26. Global Ebola Virus Vaccine Sales Share by Type (2021-2026)
Table 27. Global Ebola Virus Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Ebola Virus Vaccine Revenue Share by Type (2021-2026)
Table 29. Global Ebola Virus Vaccine Price (K MT) by Type (2021-2026)
Table 30. Global Ebola Virus Vaccine Sales (K MT) by Application (2015-2020)
Table 31. Global Ebola Virus Vaccine Sales Share by Application (2015-2020)
Table 32. Global Ebola Virus Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Ebola Virus Vaccine Price (K MT) by Application (2015-2020)
Table 34. Global Ebola Virus Vaccine Sales (K MT) by Application (2021-2026)
Table 35. Global Ebola Virus Vaccine Sales Share by Application (2021-2026)
Table 36. Global Ebola Virus Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Ebola Virus Vaccine Revenue Share by Application (2021-2026)
Table 38. Global Ebola Virus Vaccine Price (K MT) by Application (2021-2026)
Table 39. United States Ebola Virus Vaccine Sales (K MT) by Company (2015-2020)
Table 40. United States Ebola Virus Vaccine Sales Market Share by Company (2015-2020)
Table 41. United States Ebola Virus Vaccine Sales (K MT) by Type (2015-2020)
Table 42. United States Ebola Virus Vaccine Sales Market Share by Type (2015-2020)
Table 43. United States Ebola Virus Vaccine Sales (K MT) by Application (2015-2020)
Table 44. United States Ebola Virus Vaccine Sales Market Share by Application (2015-2020)
Table 45. Europe Ebola Virus Vaccine Sales (K MT) by Company (2015-2020)
Table 46. Europe Ebola Virus Vaccine Sales Market Share by Company (2015-2020)
Table 47. Europe Ebola Virus Vaccine Sales (K MT) by Type (2015-2020)
Table 48. Europe Ebola Virus Vaccine Sales Market Share by Type (2015-2020)
Table 49. Europe Ebola Virus Vaccine Sales (K MT) by Application (2015-2020)
Table 50. Europe Ebola Virus Vaccine Sales Market Share by Type (2015-2020)
Table 51. China Ebola Virus Vaccine Sales (K MT) by Company (2015-2020)
Table 52. China Ebola Virus Vaccine Sales Market Share by Company (2015-2020)
Table 53. China Ebola Virus Vaccine Sales (K MT) by Type (2015-2020)
Table 54. China Ebola Virus Vaccine Sales Market Share by Type (2015-2020)
Table 55. China Ebola Virus Vaccine Sales (K MT) by Application (2015-2020)
Table 56. China Ebola Virus Vaccine Sales Market Share by Application (2015-2020)
Table 57. Japan Ebola Virus Vaccine Sales (K MT) by Company (2015-2020)
Table 58. Japan Ebola Virus Vaccine Sales Market Share by Company (2015-2020)
Table 59. Japan Ebola Virus Vaccine Sales (K MT) by Type (2015-2020)
Table 60. Japan Ebola Virus Vaccine Sales Market Share by Type (2015-2020)
Table 61. Japan Ebola Virus Vaccine Sales (K MT) by Application (2015-2020)
Table 62. Japan Ebola Virus Vaccine Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Ebola Virus Vaccine Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Ebola Virus Vaccine Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Ebola Virus Vaccine Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Ebola Virus Vaccine Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Ebola Virus Vaccine Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Ebola Virus Vaccine Sales Market Share by Application (2015-2020)
Table 69. India Ebola Virus Vaccine Sales (K MT) by Company (2015-2020)
Table 70. India Ebola Virus Vaccine Sales Market Share by Company (2015-2020)
Table 71. India Ebola Virus Vaccine Sales (K MT) by Type (2015-2020)
Table 72. India Ebola Virus Vaccine Sales Market Share by Type (2015-2020)
Table 73. India Ebola Virus Vaccine Sales (K MT) by Application (2015-2020)
Table 74. India Ebola Virus Vaccine Sales Market Share by Application (2015-2020)
Table 75. Bavarian Nordic Corporation Information
Table 76. Bavarian Nordic Description and Business Overview
Table 77. Bavarian Nordic Ebola Virus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Bavarian Nordic Ebola Virus Vaccine Product
Table 79. Bavarian Nordic Recent Development
Table 80. Crucell Corporation Information
Table 81. Crucell Description and Business Overview
Table 82. Crucell Ebola Virus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Crucell Ebola Virus Vaccine Product
Table 84. Crucell Recent Development
Table 85. Fab Entech Corporation Information
Table 86. Fab Entech Description and Business Overview
Table 87. Fab Entech Ebola Virus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Fab Entech Ebola Virus Vaccine Product
Table 89. Fab Entech Recent Development
Table 90. Inovio Pharmaceuticals Corporation Information
Table 91. Inovio Pharmaceuticals Description and Business Overview
Table 92. Inovio Pharmaceuticals Ebola Virus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Inovio Pharmaceuticals Ebola Virus Vaccine Product
Table 94. Inovio Pharmaceuticals Recent Development
Table 95. Microbiotix Corporation Information
Table 96. Microbiotix Description and Business Overview
Table 97. Microbiotix Ebola Virus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Microbiotix Ebola Virus Vaccine Product
Table 99. Microbiotix Recent Development
Table 100. Mitsubishi Tanabe Pharma Corporation Information
Table 101. Mitsubishi Tanabe Pharma Description and Business Overview
Table 102. Mitsubishi Tanabe Pharma Ebola Virus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Mitsubishi Tanabe Pharma Ebola Virus Vaccine Product
Table 104. Mitsubishi Tanabe Pharma Recent Development
Table 105. Profectus Biosciences Corporation Information
Table 106. Profectus Biosciences Description and Business Overview
Table 107. Profectus Biosciences Ebola Virus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Profectus Biosciences Ebola Virus Vaccine Product
Table 109. Profectus Biosciences Recent Development
Table 110. SIGA Technologies Corporation Information
Table 111. SIGA Technologies Ebola Virus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. SIGA Technologies Description and Business Overview
Table 113. SIGA Technologies Ebola Virus Vaccine Product
Table 114. SIGA Technologies Recent Development
Table 115. Tekmira Pharmaceuticals Corporation Information
Table 116. Tekmira Pharmaceuticals Ebola Virus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Tekmira Pharmaceuticals Description and Business Overview
Table 118. Tekmira Pharmaceuticals Ebola Virus Vaccine Product
Table 119. Tekmira Pharmaceuticals Recent Development
Table 120. Vaxart Corporation Information
Table 121. Vaxart Description and Business Overview
Table 122. Vaxart Ebola Virus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Vaxart Ebola Virus Vaccine Product
Table 124. Vaxart Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Ebola Virus Vaccine Distributors List
Table 128. Ebola Virus Vaccine Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Ebola Virus Vaccine Product Picture
Figure 2. Global Ebola Virus Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Ebola Virus Vaccine Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Medical Center Examples
Figure 8. Global Ebola Virus Vaccine Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Ebola Virus Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Ebola Virus Vaccine Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Ebola Virus Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Ebola Virus Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Ebola Virus Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Ebola Virus Vaccine Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Ebola Virus Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Ebola Virus Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Ebola Virus Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Ebola Virus Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Ebola Virus Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Ebola Virus Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Ebola Virus Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Ebola Virus Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Ebola Virus Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Ebola Virus Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Ebola Virus Vaccine Players Market Share by Revenue in Ebola Virus Vaccine 2015 & 2019
Figure 26. Ebola Virus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Ebola Virus Vaccine Revenue Share by Type (2015-2020)
Figure 28. Global Ebola Virus Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Ebola Virus Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global Ebola Virus Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Ebola Virus Vaccine Sales Market Share by Type in 2019
Figure 32. United States Ebola Virus Vaccine Sales Market Share by Type in 2019
Figure 33. Europe Ebola Virus Vaccine Sales Market Share by Company in 2019
Figure 34. Europe Ebola Virus Vaccine Sales Market Share by Type in 2019
Figure 35. Europe Ebola Virus Vaccine Sales Market Share by Application in 2019
Figure 36. China Ebola Virus Vaccine Sales Market Share by Company in 2019
Figure 37. China Ebola Virus Vaccine Sales Market Share by Type in 2019
Figure 38. China Ebola Virus Vaccine Sales Market Share by Application in 2019
Figure 39. Japan Ebola Virus Vaccine Sales Market Share by Company in 2019
Figure 40. Japan Ebola Virus Vaccine Sales Market Share by Type in 2019
Figure 41. Japan Ebola Virus Vaccine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Ebola Virus Vaccine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Ebola Virus Vaccine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Ebola Virus Vaccine Sales Market Share by Application in 2019
Figure 45. India Ebola Virus Vaccine Sales Market Share by Company in 2019
Figure 46. India Ebola Virus Vaccine Sales Market Share by Type in 2019
Figure 47. India Ebola Virus Vaccine Sales Market Share by Application in 2019
Figure 48. Bavarian Nordic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Crucell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Fab Entech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Inovio Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Microbiotix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Mitsubishi Tanabe Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Profectus Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. SIGA Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Tekmira Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Vaxart Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Key Raw Materials Price Trend
Figure 59. Manufacturing Cost Structure of Ebola Virus Vaccine
Figure 60. Manufacturing Process Analysis of Ebola Virus Vaccine
Figure 61. Ebola Virus Vaccine Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Porter's Five Forces Analysis
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed